| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Avicanna Inc. (OTCQX:AVCNF) (TSX:AVCN) (FSE:0NN) has closed of the previously announced acquisition of the Medical Cannabis by Shopper’s Business from Shoppers Drug Mart and launched an all-new medical cannabis care platform, MyMedi.ca.
Today, MyMedi.ca, a medical cannabis care platform, has officially launched nationwide in Canada. The platform's features include:
A medical cannabis marketplace featuring approximately 200 unique products supplied by a network of 35 brands from various Canadian licensed producers.
Pharmacist-led fully bilingual (English and French) patient care service programs including pharmacovigilance, compassionate pricing, and insurance adjudication in compliance with standards established by private and public payers.
Patient education programs and informational resources, including harm reduction strategies and risk mitigation.
Medical education, training, and resources available to health care practitioners, hospitals, clinics, and institutions, along with potential collaboration opportunities, through the company’s medical affairs department
“We are pleased to have closed the acquisition of the Business from Shoppers Drug Mart and recognize this as a transformational milestone in the life of our company. We would like to express our gratitude to the incredible network of collaborators who came together to ensure a smooth transition for the patients and deliver this medical platform that is adhering to required standards of patient privacy and care. We are motivated to meet the needs of our new patients through MyMedi.ca and welcome the thousands of patients that have transitioned over from the Medical Cannabis by Shoppers platform,” stated Aras Azadian, CEO of Avicanna.
Benzinga Cannabis Capital Conference
The Benzinga Cannabis Capital Conference, the place where deals get done, is returning to Chicago this Sept 27-28 for its 17th edition. Get your tickets today before prices increase and secure a spot at the epicenter of cannabis investment and branding.
Related News
Avicanna Reveals The Initial Network Of Brands On Its Cannabis Care Platform
